PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 6850576-0 1983 Inhibition by 2(3)-tert-butyl-4-hydroxyanisole and other antioxidants of epidermal ornithine decarboxylase activity induced by 12-O-tetradecanoylphorbol-13-acetate. Butylated Hydroxyanisole 14-46 ornithine decarboxylase, structural 1 Mus musculus 83-106 1991991-3 1991 TPA-induced ODC activity was markedly inhibited by the topical application of 55 mumol of BHA (the inhibition rate at 6 h was about 80%). Butylated Hydroxyanisole 90-93 ornithine decarboxylase, structural 1 Mus musculus 12-15 1991991-4 1991 In Northern and dot-blot analysis, the TPA-induced increase in ODC mRNA was shown to be markedly reduced by the same dose of BHA (the inhibition rate at 4 h was about 60%). Butylated Hydroxyanisole 125-128 ornithine decarboxylase, structural 1 Mus musculus 63-66 1991991-5 1991 These results suggest the involvement of a decrease in ODC gene expression in the mechanism of the inhibition of ODC activity by BHA. Butylated Hydroxyanisole 129-132 ornithine decarboxylase, structural 1 Mus musculus 55-58 1991991-5 1991 These results suggest the involvement of a decrease in ODC gene expression in the mechanism of the inhibition of ODC activity by BHA. Butylated Hydroxyanisole 129-132 ornithine decarboxylase, structural 1 Mus musculus 113-116 6850576-2 1983 Mice maintained on a diet containing 0.75% BHA for 8 days showed a 50% reduction in maximal ODC induction following treatment with TPA when compared to mice fed a control diet. Butylated Hydroxyanisole 43-46 ornithine decarboxylase, structural 1 Mus musculus 92-95 6850576-3 1983 Topical application of BHA (55 mumol) 30 min prior to TPA treatment (17 nmol) elicited an 80% inhibition of promoter-induced ODC activity. Butylated Hydroxyanisole 23-26 ornithine decarboxylase, structural 1 Mus musculus 125-128 6850576-5 1983 The inhibition by BHA was dose dependent with a dose producing a 50% inhibition of ODC induction of 6 mumol. Butylated Hydroxyanisole 18-21 ornithine decarboxylase, structural 1 Mus musculus 83-86 1401495-0 1992 Effects of butylated hydroxyanisole on ornithine decarboxylase activity induced by ultraviolet-B and PUVA in mouse skin. Butylated Hydroxyanisole 11-35 ornithine decarboxylase, structural 1 Mus musculus 39-62 1401495-1 1992 The effects of butylated hydroxyanisole (BHA), a representative phenolic antioxidant, on the activity of ornithine decarboxylase (ODC, an indicator of tumor promotion and epidermal hyperproliferation) induced by ultraviolet-B (UVB) or PUVA in mouse skin were investigated. Butylated Hydroxyanisole 15-39 ornithine decarboxylase, structural 1 Mus musculus 105-128 1401495-1 1992 The effects of butylated hydroxyanisole (BHA), a representative phenolic antioxidant, on the activity of ornithine decarboxylase (ODC, an indicator of tumor promotion and epidermal hyperproliferation) induced by ultraviolet-B (UVB) or PUVA in mouse skin were investigated. Butylated Hydroxyanisole 15-39 ornithine decarboxylase, structural 1 Mus musculus 130-133 1401495-1 1992 The effects of butylated hydroxyanisole (BHA), a representative phenolic antioxidant, on the activity of ornithine decarboxylase (ODC, an indicator of tumor promotion and epidermal hyperproliferation) induced by ultraviolet-B (UVB) or PUVA in mouse skin were investigated. Butylated Hydroxyanisole 41-44 ornithine decarboxylase, structural 1 Mus musculus 105-128 1401495-1 1992 The effects of butylated hydroxyanisole (BHA), a representative phenolic antioxidant, on the activity of ornithine decarboxylase (ODC, an indicator of tumor promotion and epidermal hyperproliferation) induced by ultraviolet-B (UVB) or PUVA in mouse skin were investigated. Butylated Hydroxyanisole 41-44 ornithine decarboxylase, structural 1 Mus musculus 130-133 1401495-2 1992 By topical application of BHA (55 mumol), PUVA-induced ODC activity was suppressed by about 60% at both 12 h and 24 h after treatment. Butylated Hydroxyanisole 26-29 ornithine decarboxylase, structural 1 Mus musculus 55-58 1991991-0 1991 Effects of butylated hydroxyanisole on ornithine decarboxylase activity and its gene expression induced by phorbol ester tumor promoter. Butylated Hydroxyanisole 11-35 ornithine decarboxylase, structural 1 Mus musculus 39-62 1991991-2 1991 In this study, we investigated the effect of BHA on the activity of ornithine decarboxylase (ODC, an indicator of tumor promotion) and its gene expression induced by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) in mouse skin. Butylated Hydroxyanisole 45-48 ornithine decarboxylase, structural 1 Mus musculus 68-91 1991991-2 1991 In this study, we investigated the effect of BHA on the activity of ornithine decarboxylase (ODC, an indicator of tumor promotion) and its gene expression induced by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) in mouse skin. Butylated Hydroxyanisole 45-48 ornithine decarboxylase, structural 1 Mus musculus 93-96 2992824-1 1985 Previously it was shown that lipophilic analogs of a free-radical scavenger, 2(3)-tert-butyl-4-hydroxyanisole (BHA), inhibit ornithine decarboxylase (ODC) activity which is induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in mouse epidermis. Butylated Hydroxyanisole 77-109 ornithine decarboxylase, structural 1 Mus musculus 125-148 2992824-1 1985 Previously it was shown that lipophilic analogs of a free-radical scavenger, 2(3)-tert-butyl-4-hydroxyanisole (BHA), inhibit ornithine decarboxylase (ODC) activity which is induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in mouse epidermis. Butylated Hydroxyanisole 77-109 ornithine decarboxylase, structural 1 Mus musculus 150-153 2992824-1 1985 Previously it was shown that lipophilic analogs of a free-radical scavenger, 2(3)-tert-butyl-4-hydroxyanisole (BHA), inhibit ornithine decarboxylase (ODC) activity which is induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in mouse epidermis. Butylated Hydroxyanisole 111-114 ornithine decarboxylase, structural 1 Mus musculus 125-148 2992824-1 1985 Previously it was shown that lipophilic analogs of a free-radical scavenger, 2(3)-tert-butyl-4-hydroxyanisole (BHA), inhibit ornithine decarboxylase (ODC) activity which is induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in mouse epidermis. Butylated Hydroxyanisole 111-114 ornithine decarboxylase, structural 1 Mus musculus 150-153 2992824-8 1985 These results imply that lipophilic BHA analogs inhibit TPA-induced ODC activity by scavenging free radicals other than O-2. Butylated Hydroxyanisole 36-39 ornithine decarboxylase, structural 1 Mus musculus 68-71 6850576-1 1983 The relationship between reactive oxygen and/or free radical species and tumor promotion was evaluated by investigating the inhibitory effects of 2(3)-tert-butyl-4-hydroxyanisole (BHA) and other antioxidants on the induction of ornithine decarboxylase (ODC) activity in mouse epidermis by a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA). Butylated Hydroxyanisole 146-178 ornithine decarboxylase, structural 1 Mus musculus 228-251 6850576-1 1983 The relationship between reactive oxygen and/or free radical species and tumor promotion was evaluated by investigating the inhibitory effects of 2(3)-tert-butyl-4-hydroxyanisole (BHA) and other antioxidants on the induction of ornithine decarboxylase (ODC) activity in mouse epidermis by a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA). Butylated Hydroxyanisole 146-178 ornithine decarboxylase, structural 1 Mus musculus 253-256 6850576-1 1983 The relationship between reactive oxygen and/or free radical species and tumor promotion was evaluated by investigating the inhibitory effects of 2(3)-tert-butyl-4-hydroxyanisole (BHA) and other antioxidants on the induction of ornithine decarboxylase (ODC) activity in mouse epidermis by a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA). Butylated Hydroxyanisole 180-183 ornithine decarboxylase, structural 1 Mus musculus 228-251